Amanote Research
Register
Sign In
MicroRNAs in Cancer Treatment-Induced Cardiotoxicity
Cancers
- Switzerland
doi 10.3390/cancers12030704
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
March 17, 2020
Authors
Laura Pellegrini
Sara Sileno
Marco D’Agostino
Eleonora Foglio
Maria Cristina Florio
Vincenzo Guzzanti
Matteo Antonio Russo
Federica Limana
Alessandra Magenta
Publisher
MDPI AG
Related search
Concepts in Cardio-Oncology: Definitions, Mechanisms, Diagnosis and Treatment Strategies of Cancer Therapy-Induced Cardiotoxicity
Future Oncology
Medicine
Cancer Research
Oncology
Strategies to Prevent Anthracycline-Induced Cardiotoxicity in Cancer Survivors
Cardio-Oncology
Treatment-Induced Cardiotoxicity in Breast Cancer: A Review of the Interest of Practicing a Physical Activity
Oncology
Medicine
Cancer Research
Oncology
Role of Biomarkers in Prediction of Cardiotoxicity During Cancer Treatment
Current Treatment Options in Cardiovascular Medicine
Cardiovascular Medicine
Cardiology
HER2+ Breast Cancer Treatment and Cardiotoxicity: Monitoring and Management
Breast Cancer Research and Treatment
Cancer Research
Oncology
Therapeutic Prospects of microRNAs in Cancer Treatment Through Nanotechnology
Drug Delivery and Translational Research
Pharmaceutical Science
Oxidative Stress in Radiation-Induced Cardiotoxicity
Oxidative Medicine and Cellular Longevity
Biochemistry
Medicine
Cell Biology
Aging
MicroRNAs in Cancer
Annual Review of Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Trastuzumab in the Treatment of Metastatic Breast Cancer : Anticancer Therapy Versus Cardiotoxicity
Circulation
Cardiovascular Medicine
Physiology
Cardiology